The effect of pro-inflammatory cytokines on the expression and activity of sGC and cGMP-PDEs was determined in intestinal longitudinal smooth muscle. In control muscle cells, cGMP levels are regulated via activation of sGC and PDE5; the activity of the later is regulated via feedback phosphorylation by PKG. In muscle cells isolated from muscle strips cultured with IL-1β or TNF-α or obtained from the colon of TNBS-treated mice, expression of iNOS was induced and sGC was S-nitrosylated resulting in attenuation of NO-induced sGC activity and cGMP formation. The effect of cytokines on sGC Snitrosylation and activity was blocked by the iNOS inhibitor, 1400W. The effect of cytokines on cGMP levels measured in the absence of IBMX, however, was partly reversed by 1400W or PDE1 inhibitor vinpocetine and completely reversed by a combination of 1400W and vinpocetine. Expression of PDE1A was induced and was accompanied by an increase in PDE1A activity in muscle cells isolated from muscle strips cultured with IL-1β or TNF-α or obtained from the colon of TNBS-treated mice; the effect of cytokines on PDE1 expression and activity was blocked by MG132, an inhibitor of NF-κB activity. NO-induced muscle relaxation was inhibited in longitudinal muscle cells isolated from muscle strips cultured with IL-1β or TNF-α or obtained from the colon of TNBS-treated mice and this inhibition was completely reversed by the combination of both 1400W and vinpocetine.
INTRODUCTION
Relaxant transmitter nitric oxide (NO) plays an important role in gastrointestinal smooth muscle relaxation. The effects of NO are mediated by activation of soluble guanylyl cyclase (sGC) which catalyzes the conversion of GTP into cGMP (Friebe et al., 1997; Mayer, 1998; Krumenacker et al., 2004; Francis et al., 2010; Derbyshire and Marletta, 2012) . The majority of cGMP effects are mediated by activation of cGMPdependent protein kinase, which phosphorylates several proteins regulating Ca 2+ mobilization and MLCP activity, key determinants of smooth muscle contraction (Murthy and Makhlouf, 1998; Kamm and Stull, 2001; Somlyo et al., 2004; Murthy, 2006; De Godoy and Rattan, 2012) . The strength and duration of cGMP signaling are regulated by the balance between sGC and cGMP-specific phosphodiesterase (PDE) activity (Soderling and Beavo, 2000; Francis et al., 2001; Rybalkin et al., 2003; Corbin et al., 2009 (Mayer et al., 1998; Krumenacker et al., 2004; Derbyshire and Marletta, 2012) . Binding of NO to the heme greatly increases the catalytic activity of sGC. Expression of Expression of sGC subunits has been shown to be regulated by both transcriptional and post-transcriptional mechanisms in response to cytokines and growth factors (Krumenacker et al., 2001; Pyriochou and Pappetropoulos, 2005; Xia et al., 2007; Derbyshire and Marletta, 2012) . Activity of sGC has been shown to be regulated by posttranslational mechanisms such as phosphorylation, S-nitrosylation and protein-protein interactions (Murthy, 2001; Rybalkin et al., 2003; Sayed et al., 2007; Zhou et al., 2008; Mayer et al., 2009; Su, 2014) .
PDEs, which hydrolyze cyclic nucleotides cAMP or cGMP to the inactive noncyclic 5'AMP or 5'GMP, respectively, are classified based on their regulatory and catalytic properties into 11 families. PDE5, 6, and 9 are specific for cGMP, whereas PDE1, 2, and 3 hydrolyze both cAMP and cGMP, albeit with different affinity (Sharma et al., 2006; Ahmad et al., 2012) . PDE5 is a dimer with cGMP-binding sites in its regulatory N-terminal and catalytic C-terminal domains (Soderling and Beavo, 2000; Francis et al., 2001; Rybalkin et al., 2003; Corbin et al., 2009 ). PDE5 activity is stimulated via binding of cGMP and PKG-mediated phosphorylation of PDE5 at a conserved serine residue in the N-terminal region (Francis et al., 2001; Rybalkin et al., 2003) . PDE5 expression is abundant in smooth muscle and plays an important role in the regulation of cGMP levels and smooth muscle relaxation (Murthy, 2001; . PDE1 (PDE1A and PDE1B) hydrolyzes cGMP with higher affinity and is regulated by Ca 2+ /calmodulin (Sharma et al., 2006) . Both PDE2 and PDE3 (PDE3A and PDE3B) hydrolyze cAMP and cGMP with similar affinity, but due to higher catalytic rate of PDE3 for cAMP than cGMP, cGMP acts as a competitive inhibitor and PDE3 is known as cGMP-inhibited cAMP phosphodiesterase (Ahmad et al., 2012) .
Recent studies have determined the changes in the expression and/or activity of adenylyl cyclase 5/6 and cAMP-specific PDE4D5 in response to inflammatory cytokines (IL-1β and TNF-α) in vitro and TNBS-induced colonic inflammation in vivo in longitudinal smooth muscle (Mahavadi et al., 2014) . Inflammation induced increase in PDE4D5 activity and decrease in AC5/6 activity leading to decrease in cAMP formation and a decrease in smooth muscle relaxation. The aim of the present study is to characterize the expression and activity of sGC and cGMP-PDE isoforms by cytokines in vitro and inflammation in vivo that result in altered smooth muscle relaxation. Our results demonstrated that sGC and PDE5 were expressed in normal longitudinal smooth muscle. In response to cytokines in vitro and during inflammation iNOS expression was induced and sGC activity was decreased as a result of s-nitrosylation of sGC.
Concurrently, PDE1A expression was induced via NF-κB pathway. The combined effects of iNOS-mediated S-nitrosylation of sGC and NF-κB-dependent PDE1 expression decreased cGMP formation and longitudinal smooth muscle relaxation during inflammation. trinitrobenzene sulphonic acid (TNBS) as described previously (Hazelgrove et al., 2009; Alkahtani et al., 2013; Nalli et al., 2014; Al-Shboul et al., 2014; Mahavadi et al., 2014) .
METHODS

Materials
Adult male mice (C57BL/6J; 6 to 8-weeks old) were anesthetized, and 100 µl of TNBS (2.5% in 50% ethanol (v/v)) was instilled intrarectally and mice were euthanized 3 days after the induction of inflammation. Control mice were treated with vehicle. Body weight and stool consistency were evaluated daily. Colonic tissue from mice treated with TNBS exhibited typical histological characteristics of colitis (Alkahtani et al., 2013; Nalli et al., 2014; Al-Shboul et al., 2014; Mahavadi et al., 2014) . Distal colonic segments of 2-3-centimeter-long were obtained from control and TNBS-treated mice and muscle cells from longitudinal muscle layer were obtained as described previously (Murthy et al., 2002 (Murthy et al., , 2003 Mahavadi et al., , 2014 .
Assay for soluble guanylyl cyclase activity. Soluble guanylyl cyclase activity was measured by using [α-
32
P]GTP as substrate as described previously (Murthy, 2001 ).
Homogenates of muscle cells were incubated for 15 min at 37 o C in 50 mM Tris-HCl (pH7.4), 2 mM cGMP, 0.1 mM GTP, 1 mM IBMX, 5 mM MgCl 2 , 100 mM NaCl, 5 mM creatine phosphate, 50 U/ml of creatine phosphokinase, and 0.5 mM [α- Assay for phosphodiesterase (PDE) activity. PDE5 and PDE1A activity was measured in immunoprecipitates of PDE5 and PDE1A as described previously (Wyatt et al., 1998; Murthy, 2001; . One ml aliquots (3 X 10 6 cells/ml) of muscle cells were incubated with SNAP for 5 min. Immunoprecipitates were washed in a The results were expressed as counts per minute per mg protein (cpm/mg protein).
Phosphorylation of PDE5 by PKG. Phosphorylation of PDE5 was measured by
immunoblot analysis using phospho-specific antibody (Ser92) as described previously (Murthy, 2001) . One ml aliquots (3 X 10
Assay for S-nitrosylation. The S-nitrosylated sGC was detected using a detection assay kit (Cayman, Ann Arbor, MI) as described previously (Mahavadi et al., 2014) . In brief, sGC was immunoprecipitated with anti-sGC conjugated with protein A/G plus agarose beads. Immunoprecipitated sGC was released by boiling the beads for 5 min, the free thiols were blocked, then S-NO bonds were cleaved. The proteins were labeled with biotin by biotinylation of the newly formed SH groups. The labeled proteins were then analyzed by SDS/PAGE and transferred to PVDF membranes for western blot.
Radioimmunoassay for cGMP. Cyclic GMP production was measured by radioimmunoassay as described previously (Murthy, 2001; . Briefly, muscle cells (3 x 10 6 cells) were treated with SNAP for 5 min and the reaction terminated with 10% trichloroacetic acid. After extraction with water-saturated diethyl ether, the lyophilized aqueous phase was reconstituted in 500 μl of 50 mM Na acetate (pH 6.2). The samples were acetylated with triethylamine/acetic anhydride (2:1) for 30 min and cGMP was measured in duplicate using 100 μl aliquots. The results were expressed as picomoles/mg protein.
Measurement of contraction and relaxation in smooth muscle cells.
Contraction in freshly dispersed colonic longitudinal muscle cells was determined by scanning micrometry (Murthy and Makhlouf, 1998; Murthy, 2001; Mahavadi et al., , 2014 ). An aliquot (0.4 ml) of cells containing approximately 10 4 cells/ml was treated with 100 µl of medium containing different concentrations of SNAP for 5 min followed by carbachol (1 µM) for 30 s and then the reaction was terminated with 1% acrolein at a final concentration of 0.1%.
The resting cell length was determined in control
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RESULTS
Regulation of cGMP levels in mouse longitudinal smooth muscle cells.
Studies in circular smooth muscle have shown the presence of sGC and PDE5 and cGMP levels in response to NO donors are regulated by stimulation of both sGC and PDE5 activities. Western blot analysis in the dispersed smooth muscle cells of colonic longitudinal muscle detected the presence of sGC and cGMP-hydrolyzing PDE5A, but not PDE1A or PDE2A or PDE3A (Fig. 1A ). In contrast, as shown previously, circular muscle cells expressed both PDE3A and PDE5A isoforms (Fig. 1A ) (Murthy, 2001; Murthy et al., 2002; Mahavadi et al., 2014 phosphorylation of PDE5A at Ser92 in a concentration-dependent manner (Fig. 1C) .
SNAP-stimulated PDE5 activity was attenuated in the presence of a selective PKG inhibitor, Rp-cGMPS (Fig. 1C) . Previous studies have shown that PDE5 activity is stimulated via binding of cGMP and PKG-mediated phosphorylation of PDE5 (Francis et al., 2001; Murthy, 2001; Rybalkin et al., 2003) . Consistent with the activation of sGC, SNAP stimulated cGMP levels in a concentration-dependent manner and the increase was augmented in the presence of Rp-cGMPS ( Fig. 2A) . Increase in cGMP levels could be due to attenuation of PDE5 activity in the presence of Rp-cGMPS. SNAP also caused a concentration-dependent inhibition of carbachol (1 µM)-induced contraction (i.e. relaxation) (Fig. 2B ). SNAP-induced relaxation was inhibited by Rp-cGMPS suggesting relaxation was mediated via PKG (Fig. 2B) . Previous studies have shown that muscle relaxation in response to PKG activating agents result from inhibition of initial increase in cytosolic Ca 2+ leading to inhibition of MLCK and/or stimulation of MLCP activity (Murthy and Makhlouf, 1998; Murthy et al., 2003; Murthy, 2006) .
Inhibition of SNAP-stimulated sGC activity in colonic longitudinal muscle cells isolated from TNBS-treated mice or from control muscle strips treated with
IL-1β or TNF-α. SNAP stimulated sGC activity in colonic longitudinal muscle cells isolated from control and TNBS-treated mice. Increase in sGC activity was attenuated and the concentration-response curve was shifted to the right in muscle cells isolated from TNBS-treated mice (Fig. 3A) . Similarly, SNAP-stimulated sGC activity was attenuated and the concentration response curve was shifted to the right in muscle cells isolated from muscle strips treated for 48 h with IL-1β (10 ng/ml) or TNF-α (1 nM) (Figs.
3B and 3C).
This article has not been copyedited and formatted. The final version may differ from this version. As shown in previous studies (Kuemmerle, 1998; Nalli et al., 2014; Mahavadi et al., 2014) , NOS-III (iNOS) was induced in colonic longitudinal smooth muscle isolated from the colon of TNBS-treated mice or control muscle strips treated for 48 h with IL-1β or TNF-α (Fig. 3D) . Soluble GC was s-nitrosylated in colonic longitudinal muscle cells isolated from TNBS-treated mice or from muscle strips treated for 48 h with IL-1β or TNF-α (Fig. 3D) . S-nitrosylation of sGC, but not iNOS expression, was blocked in cells isolated from muscle strips treated with IL-1β or TNF-α in the presence of iNOS inhibitor 1400W suggesting that s-nitrosylation was mediated by iNOS (Fig. 3D ). It has been suggested that S-nitrosylation of cysteine residues in sGC causes inhibition of its activity (Mayer et al., 1998 (Mayer et al., , 2009 Sayed et al., 2007 Sayed et al., , 2009 (Fig. 5C ). Western blot analysis also showed upregulation of PDE1A, but not PDE5 expression in muscle cells isolated from the colon of TNBS-treated mice or control muscle strips treated with IL-1β or TNF-α for 48 h (Fig.   5D ). Expression of PDE1A was blocked in the presence of a NF-κB inhibitor, MG132
(10 µM) ( partly reversed the inhibition of cGMP and completely reversed the inhibition in combination with 1400W (Fig. 6 ).
PDE1A activity was also augmented in colonic longitudinal smooth muscle isolated from the colon of TNBS-treated mice or control muscle strips treated for 48 h with IL-1β or TNF-α (Fig. 7A ). Increase in PDE1A activity in response to cytokines was blocked in the presence of a NF-κB inhibitor, MG132 (10 µM) and the effect of MG132
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contributed to nearly 60% of total hydrolyzing PDE activity in colonic muscle cells isolated from the colon of TNBS-treated mice or control muscle strips treated for 48 h with IL-1β or TNF-α compared to ~6% in muscle cells from control mice (Fig. 7B ).
Together these results indicate that PDE1A induction during inflammation contributes to the inhibition of cGMP formation. SNAP-stimulated PDE5 activity, in contrast, was not significantly different in colonic muscle cells of control (3986±452 cpm/mg protein) and TNBS-treated mice (4145±567 cpm/mg protein) or from muscle cells isolated from strips treated with IL-1β (4278±510 cpm/mg protein) or TNF-α (4012±602 cpm/mg protein) compared to control (3881±595 cpm/mg protein).
Inhibition of SNAP-stimulated relaxation in colonic longitudinal muscle cells isolated from TNBS-treated mice or from control muscle strips treated with
IL-1β or TNF-α. SNAP-stimulated relaxation, measured in the absence of IBMX, was inhibited in longitudinal muscle cells isolated from control muscle strips treated for 48 h with IL-1β or TNF-α (Fig. 8) . Maximal relaxation induced by 10 μ M SNAP was inhibited by 60-65% (p< 0.05; n=5-6). Inhibition of relaxation induced by treatment with IL-1β or TNF-α was partly reversed in the presence of 1400W, vinpocetine or MG132 (Fig. 8) .
SNAP induced relaxation in colonic longitudinal muscle cells isolated from control and TNBS-treated mice. Relaxation, however, was attenuated and the concentrationresponse curve was shifted to the right in muscle cells isolated from TNBS-treated mice (Fig. 9A) . Similarly, SNAP-induced relaxation was attenuated and the concentration response curve was shifted to the right in muscle cells isolated from muscle strips expression and increase in cGMP hydrolysis (Fig. 10 ). As shown in previous studies, relaxation in response to cAMP elevating agents (e.g., forskolin) was also inhibited during inflammation in vivo and in response to proinflammatory cytokines in vitro (Mahavadi et al., 2014) . Inhibition of relaxation in response to forskolin was due to inhibition of AC5/6 via iNOS-mediated S-nitrosylation and inhibition of AC5/6 activity and PI3 kinase-and ERK1/2-mediated phosphorylation and stimulation of cAMPspecific PDE4D5 activity. The combined inhibition of AC5/6 activity and stimulation of PDE4D5 decreased cAMP formation and smooth muscle relaxation.
Proinflammatory cytokines acting via transcription factors and regulatory kinases induce changes in the expression and activity of various signaling molecules that regulate smooth muscle contraction and relaxation (Akiho et al., 2002; Shi et al., 2003; Cao et al., 2004; Jin et al., 2004; Salinthone et al., 2004; Singer et al., 2004; Shi and Sarna, 2005; Zhao et al., 2005 Zhao et al., , 2006 Khan and Collins, 2006; Ohama et al., 2007; Ihara et al., 2012; Shea-Donohue et al., 2012; Yang et al., 2013) . Previous studies have identified that signaling pathways that mediate initial and sustained contraction in intestinal longitudinal muscle are distinct from those in circular muscle (Grider and Makhlouf, 1988; Murthy, 2006) . Exposure to proinflammatory cytokines leads to hypercontractility of longitudinal and hypocontractility of circular muscle and the differential effects of cytokines are due to differences in the signaling targets.
Several studies have examined the changes in the signaling mechanisms that lead to hypocontraction of circular muscle and hypercontraction of longitudinal muscle (Matinolle et al., 1997; Akiho et al., 2002; Ohama et al., 2003; Shi et al., 2003; Cao et al., 2004; Jin et al., 2004; Shi and Sarna, 2005; Zhao et al., 2005 Zhao et al., , 2006 Khan and Collins, 2006; Ohama et al., 2007) expression. The contribution of PDE1A to total cGMP hydrolyzing activity was increased during inflammation. PDE5 expression and activity was not altered in TNBStreated mice and muscle strips exposed to either cytokine. PDE1A hydrolyzes cGMP with much higher affinity than cAMP and the activity of PDE1 family members including PDE1A are stimulated by Ca 2+ /calmodulin, albeit with different affinities. PDE1A has higher affinity for calmodulin and is stimulated at much lower concentrations of Ca 2+ than the other isozymes (Sharma et al., 2006) . Induction of PDE1A activity leading to decrease in cGMP levels in response to cytokines could also contribute to the hypercontractile response of longitudinal muscle during inflammation. The cytokine- Lysates were used to measure iNOS expression and S-nitrosylation of sGC (sn-sGC)
as described in the Methods. 
